Comorbidity of Migraine and Epilepsy in Pediatrics: A Review
Jasna Jancic1, Vesna Djuric2, Boris Hencic2
11 Clinic of Neurology and Psychiatry for Children and Youth, Medical Faculty, University of Belgrade, Serbia.
Insights
Migraine and epilepsy share clinical features and treatments in children. Further research is needed to understand their shared causes and improve therapies for these chronic neurologic disorders.
Area of Science:
- Neurology
- Pediatrics
Background:
- Migraine and epilepsy are chronic neurologic disorders with overlapping clinical symptoms.
- Pediatric populations exhibit significant similarities between these two conditions.
Purpose of the Study:
- To review and highlight the similarities between migraine and epilepsy in children.
- To explore epidemiologic, pathophysiological, genetic, clinical, and pharmacologic aspects of their comorbidity.
Main Methods:
- Literature review focusing on pediatric migraine and epilepsy.
- Analysis of shared clinical features, genetic factors, and treatment strategies.
Main Results:
- Migraine and epilepsy share commonalities in epidemiology, pathophysiology, genetics, and clinical presentation.
- Pharmacologic treatments for migraine prophylaxis, including antiepileptic drugs and calcium channel blockers, show potential.
- Nonpharmacologic interventions like dietary therapy, supplements, and vagal nerve stimulation are also considered.
Conclusions:
- Further research is essential to elucidate the pathophysiological and genetic underpinnings of migraine and epilepsy comorbidity.
- Randomized controlled trials are needed to evaluate both pharmacologic and nonpharmacologic treatments for improved therapeutic approaches.
Abstract:
Migraine and epilepsy are classified as chronic paroxysmal neurologic disorders sharing many clinical features, as well as possible treatment options. This review highlights the similarities between migraine and epilepsy in pediatrics, focusing on epidemiologic, pathophysiological, genetic, clinical, and pharmacologic aspects. Despite the fact that several syndromes share symptoms of both migraine and epilepsy, further research is needed to clarify the pathophysiological and genetic basis of their comorbidity. Drugs used for prophylactic therapy of migraine and epilepsy have similar pharmacologic properties. The role of epileptic pharmacotherapy in the prophylaxis of migraine is assessed, including the use of conventional antiepileptic drugs, calcium channel blockers, and nonpharmacologic methods such as dietary therapy, supplements, and vagal nerve stimulation. Further randomized, controlled clinical trials assessing pharmacologic and nonpharmacologic methods for the treatment of both disorders are essential, in order to initiate new therapeutic approaches.
More Related Videos
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism


